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Purpose: Mycotic keratitis is a major cause of corneal blindness in India. A proper understanding of the pathogenesis
may help in refining the existing treatment. The purpose of this study is to examine the total tear protein profile of fungal
keratitis patients, which may have a bearing on pathogenesis and disease progression.
Methods: Tear samples were collected from culture positive fungal keratitis patients. Tears from the uninfected fellow
eye and from other healthy individuals served as controls. Two-dimensional electrophoresis (2DE) was used for the
separation of fractionated tear proteins, and selected protein spots, which showed differential expressions, were identified
using matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) mass spectrometry. Wherever needed, tag
sequencing of peptide fragments using post source decay (PSD) was done to confirm the identification.
Results: The glutaredoxin-related protein was expressed only in the tears of fungal keratitis patients. Six other normal
tear proteins were present in both samples but with varied expression levels. Prolactin inducible protein and serum albumin
precursor were upregulated in the infected samples. Cystatin S precursor, cystatin SN precursor, cystatin, and human tear
lipocalin were downregulated in the infected samples.
Conclusions: Tears can be used as a clinical source to study the proteomic responses in patients with fungal keratitis. The
glutaredoxin-related protein is known to be produced by Aspergillus during oxidative stress conditions, and the presence
of this protein in the tears of patients with mycotic keratitis indicates that this pathogen undergoes stress-related gene
expression during infection.
In developing countries, fungi have replaced bacteria as
the most common cause of suppurative keratitis [1,2]. Very
recently, fungi have been implicated as the causative organism
in a series of contact lens-related infectious keratitis in the
United States as well [3-5]. The visual outcome following
mycotic keratitis is generally poorer than bacterial keratitis,
probably due to the lack of effective antifungal therapy [6].
There is yet no effective validated antifungal drug sensitivity
assessment [7]. While newer and newer antibacterial drugs
continue to be discovered, natamycin, which was discovered
in the 1960s, still remains the drug of choice for the treatment
of fungal keratitis [8]. Therapeutic keratoplasty performed for
mycotic keratitis is known to have a poorer prognosis than
similar surgeries done for bacterial keratitis [9].
Ocular fungal infections or ophthalmic mycoses are being
increasingly  recognized  as  the  cause  of  morbidity  and
blindness, and certain types of ophthalmic mycoses may even
be life threatening [10,11]. Fungi are opportunistic in the eye
since they rarely infect healthy, intact ocular tissues. Even the
trivial trauma of a dust particle falling on the cornea may
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disrupt the integrity of the corneal epithelium, predisposing it
to mycotic keratitis [12]. The key agent factors involved in the
pathogenesis  of  mycotic  keratitis  include  adherence,
invasiveness,  morphogenesis,  and  toxigenicity.  Fungi  that
causes keratitis, in particular Fusarium sp., sometimes invade
the anterior chamber and form a lens-iris-fungus mass at the
pupillary area, thereby interfering with the normal drainage
of the aqueous humor and leading to a rise in intraocular
pressure  [13,14].  The  morphogenetic  and  phenotypic
switching  permit  fungi  to  adapt  in  different
microenvironments and to survive in the infected host [15].
The presence of intrahyphal hyphae or hypha-in-hyphae and
thickened fungal cell walls may reflect such morphogenesis
occurring  in  fungi  that  is  invading  corneal  tissue;  these
morphological  alterations  may  constitute  a  barrier  against
antifungal drugs or host defenses [16,17] or may function as
virulence  factors  of  fungi  in  corneas  where  the  defense
mechanism have been compromised by the application of
corticosteroids [18]. Mycotoxin production may also play an
important role in the pathogenesis [12].
It is imperative that the functional and molecular aspects
of the disease be well understood to develop an effective
treatment plan. Toward this, we have reported earlier the
usefulness  of  tear  samples  in  understanding  the  cytokine
response in fungal keratitis [19]. As a sequel to this, we used
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patients with that of controls.
Proteome analysis has emerged as a powerful approach
to complement transcript analysis to examine the mechanisms
of complex multivariate diseases at the functional molecular
level. The ability to analyze posttranslational modifications
makes proteome analysis a necessary approach to disease-
specific changes.
The  proteomic  analysis  of  tears  already  showed
promising results in eye research [20-22]. The tear proteins
play an important role in maintaining the ocular surface, and
changes in tear protein components may reflect the changes
in the health of the ocular surface [23,24]. Proteomic analysis
can provide more insights about protein expression patterns,
which are associated with various pathological conditions,
and  the  identification  of  those  tear  proteins  and  their
posttranslational modifications have the potential to reveal the
mechanism of eye disease [23,25,26].
Recent  advances  in  mass  spectrometric  technology,
particularly  in  matrix-assisted  laser  desorption/ionization-
time  of  flight  (MALDI-TOF)  and  liquid  chromatography
tandem  mass  spectrometry  (LC  MS/MS)  techniques
complement and expand the scope of two-dimensional gel
electrophoresis in proteome analysis [27]. In this paper, we
used these techniques to examine the alteration in the tear
proteome in fungal keratitis and this is the first report as far
as we are aware of.
METHODS
Tear  sample  collection:  IRB  approval  from  the  Aravind
Medical Research Foundation (Madurai, India) was obtained
for this study. The Declaration of Helsinki was adhered to
when enrolling subjects. After informed consent, reflex tear
samples (100–150 μl) were collected from the infected eye of
culture positive (Aspergillus or Fusarium) fungal keratitis
patients. Tears from the fellow eye, which was not infected,
and from other healthy individuals served as controls (60–
80 μl).
Tear samples were collected using 10 µl-capillary tubes
without touching the eye globe or the lid. The samples were
centrifuged at 7800x g for 10 min at 4 °C to remove cellular
debris and stored in liquid nitrogen until analysis. Samples
were collected from patients before treatment. Protein was
estimated using Bradford’s method [28].
Sample preparation—Tear samples from 16 Fusarium
keratitis patients and 16 Aspergillus keratitis patients were
pooled (300 µg of protein per patient). Tear samples from 24
healthy individuals were pooled and used as control samples
(200 µg of protein per healthy individual). Tear samples from
the fellow eye were insufficient, hence we could not use these
as control subjects. Pooled tear samples were concentrated
using the deoxycholate precipitation protocol [29] with minor
modifications. Briefly, 500 μl of sample was treated with
5 μl of 2% deoxycholate (prepared in water), vortexed well,
and incubated at room temperature for 10 min. To the mixture,
50 μl of chilled trichloroacetic acid was added, vortexed well,
and incubated in ice for 15 min followed by centrifugation at
7800x g for 10 min at 4 °C. The supernatant was removed
carefully and 200 μl of chilled acetone was added to the pellet,
vortexed,  and  incubated  in  ice  for  10  min  followed  by
centrifugation at 7800x g for 10 min at 4 °C. The supernatant
was removed and the pellet was dried at room temperature for
20 min. The dried pellet was resuspended in 50 μl of TE buffer
(25 mM Tris, pH 7.4; 50 mM EDTA). Protein concentration
was usually about 8 μg/μl.
Isoelectric  focusing—The  protein  concentration  used
for preparative gels to be stained with colloidal coomassie
blue G-250 was 270 μg, and for the MALDI compatible silver
staining method, 50 μg of protein was used. For rehydration,
protein was diluted to 350 μl in a buffer containing 7 M Urea,
2 M thiourea, 4% CHAPS, 0.5% ampholytes, 50 mM DTT,
and 0.004% of bromophenol blue. Samples were loaded using
the  passive  rehydration  method  for  a  minimum  of  16  h.
Rehydrated strips were rinsed with water and then focused at
a temperature of 20 °C using the IPGphor IEF apparatus (GE
Healthcare, Hong Kong, China) using the following voltage
settings:  500  V  for  1  h  (step  and  hold),  1000  V  for  1  h
(gradient), 8000 V for 3 h (gradient), and 8000 V for 8 h (step
and hold). The focused strips were stored at −70 °C until the
two-dimensional analysis or were used immediately.
SDS–PAGE—The  strips  were  brought  to  room
temperature and equilibrated for 15 min each to reduce and
alkylate the proteins. The equilibration buffer contained 6 M
Urea, 2 M Thiourea, 50 mM Tris, 34.5% glycerol, 2% SDS,
and 0.005% bromophenol blue with 2% DTT for the first step,
and 2.5% iodoacetamide replaced DTT for the second step.
Strips were then placed on top of a 12.5% polyacrylamide gel
and sealed with 0.5% agarose dissolved in electrophoresis
buffer. The DALT six apparatus (GE Healthcare, Hong Kong,
China) was used for 2DE a constant temperature of 22 °C (20
W for 30 min and 60 W for 5 h). Experimental and control
samples were examined in parallel to minimize experimental
variations.
Staining—Gels were stained using colloidal coomassie
blue G-250 [30] and the MALDI compatible silver staining
method  [31]  (with  minor  modifications).  For  colloidal
coomassie staining, the gels were fixed in 40% methanol and
10% acetic acid in water for 1 h. Gels were washed three times
in water for 10 min each and then stained overnight in a
staining  solution  containing  10%  phosphoric  acid,  10%
ammonium sulfate, 0.12% coomassie blue G-250, and 20%
methanol. Gels were then destained in water.
For MALDI compatible silver staining, gels were fixed
in 40% ethanol and 10% acetic acid in water for 1 h. The gels
were then rinsed in 30% ethanol for 20 min. Gels were given
three water washes for 10 min each and then sensitized using
0.02% sodium thiosulfate for 1 min. After water wash for 10
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formalin  followed  by  another  water  wash  for  20  s.
Development was stopped with 5% acetic acid solution and
then the stained gels were washed three times in water for 10
min each.
In-gel  tryptic  digestion—In-gel  digestion  was  done
essentially as described earlier [32]. In brief, the gel pieces
were first washed two times in water for 10 min each. The
pieces were destained using 25 mM ammonium bicarbonate
made in 50% acetonitrile. The pieces were destained in 3
changes  of  the  solution  (15  min  each  change).  After
dehydration in 100% acetonitrile for 15 min, the gel pieces
were dried under vacuum for 30 min. Dried gel pieces were
rehydrated for 30 min on ice with 400 ng of trypsin dissolved
in 5 µl of 100 mM ammonium bicarbonate in 10% acetonitrile.
Excess trypsin was then removed, and the gel pieces were
covered with 20 µl of 40 mM ammonium bicarbonate in 10%
acetonitrile and incubated at 37 °C for 16 h. The tubes were
then briefly centrifuged for 5 s and the supernatant saved.
Peptides were then eluted from gel pieces using 25 µl of 0.1%
trifluoroacetic  acid  (TFA)  made  in  60%  acetonitrile  by
sonication for 3 min at a frequency of 2200 MHz in the Soltech
ultrasonic cleaner (Soltec,Milano,Italy). The tubes were then
centrifuged for 5 s and incubated for 10 min. The supernatant
obtained  after  centrifugation  was  added  to  the  first
supernatant. Acetonitrile (20 μl of 100%) was added to gel
pieces for dehydration and vortexed. The tubes were then
centrifuged for 5 s and incubated for 10 min. The supernatant
was  combined  with  the  first  two  supernatants,  and  these
extracted  peptides  were  then  dried  under  vacuum.  Dried
peptides  were  dissolved  in  5  µl  of  0.1%  TFA  in  5%
acetonitrile. Samples were desalted using Eppendorf perfect
pure  C18  tips  and  eluted  in  5  µl  of  0.1%  TFA  in  50%
acetonitrile according to the manufacturer’s instructions.
MALDI-TOF spectrometry of tryptic digests: A MALDI-TOF
analysis of extracted tryptic peptides was done as described
earlier [32]. The matrix used in this study was the α–cyano-4-
hydroxy cinnamic acid (CHCA) matrix, which was dissolved
in 70% acetonitrile and 0.03% TFA at a concentration of 2 mg/
ml.  In  some  experiments,  50  mM  ammonium  monobasic
phosphate was used as an additive. Peptide samples were
applied on a stainless steel MALDI target plate using the
sandwich method. When the CHCA matrix was used, 0.5 µl
of the matrix was first applied on the plate and allowed to dry.
A sample (0.5 µl) was applied and then immediately layered
on top with the 0.5 µl of the matrix. In some cases, the sample
was  diluted  fivefold  in  the  CHCA  matrix  containing
ammonium phosphate, and 1 µl of the sample and matrix mix
was applied. The peptide mass spectrum was acquired using
the Axima CFR plus the MALDI-TOF mass spectrometer in
reflector mode. The instrument was set to pulsed extraction
and  the  acceleration  voltage  is  20,000  V.  Calibration
standards used were bradykinin (757.39 Da), angiotensin II
(1046.54 Da), P14R (1533.85 Da) and ACTH fragment 18–
39 (2465.19 Da).
The monoisotopic peak list was generated using Kratos
LAUNCHPAD  software  version  2.4  without  using  the
smoothing  function.  Peak  filters  were  applied  to  exclude
masses lower than 750 Da. Mass peaks with the signal to noise
ratio  of  20  and  above  was  used  for  the  database  search.
MASCOT version 2.1 and 2.2 was used for database search.
Database search parameters were as follows: tolerance 0.05–
1 Da; species Homo sapiens and/or fungus; and maximum
number of missed cleavages set to one for all samples. Fixed
modifications used were carbamidomethyl C (for cysteine
modification by iodoacetamide) and variable modifications
used were oxidation of methionine and propionamide (for
cysteine modification by acrylamide). Databases used for the
search were NCBInr, MSDB, and Swissprot. The MASCOT
score was considered significant if p<0.05.
Statistical analysis: The significance of spot differences was
calculated  according  to  the  student’s  t  test  and  the
nonparametric  two-tailed  Mann–Whitney  test  with  a
confidence interval at 95%, and a p value of less than 0.05 was
considered significant. The mean and median values of in
vitro studies are based on three replicates.
RESULTS
Figure 1 shows the 2DE gel pattern of proteins from controls
as well as from Aspergillus-infected and Fusarium-infected
tear samples. The identified protein spots from silver stained
gels were selected and compared using the ImageMaster 2D
platinum version 6.0 software (GE healthcare) and quantified.
A total of 63 spots could be detected in the two gels. Among
the 63 spots, the difference could be measured for 46 spots.
The  presence  of  highly  abundant  proteins  precludes  the
resolution of additional spots.
The  glutaredoxin-related  protein  was  found  to  be
expressed only in the infected tear samples and was absent in
the control tear samples. The expression of this protein was
higher in the tear samples obtained from Aspergillus keratitis
than in the tear samples obtained from Fusarium keratitis. In
addition, six other normal tear proteins were also shown to be
differentially regulated. Among the six normal tear proteins,
prolactin inducible protein and serum albumin precursor were
upregulated while cystatin S precursor, cystatin SN precursor,
cystatin, and human tear lipocalin were downregulated in the
infected tear when compared to the control tear sample (Figure
2).
Differential  expression  of  tear  proteins:  In  analyzing
differentially expressed spots in the control tear samples and
the Fusarium tear and Aspergillus tear samples, 11 spots were
upregulated in the Fusarium tear samples when compared to
the control tear samples and eight spots were upregulated in
the Aspergillus tear samples when compared to control tear
samples. To minimize the error in calculating the intensity
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analyzed by calculating the ratio of percent intensity across
all replicate gels. Among the 11 spots upregulated in the
Fusarium tear samples, variation of expression level of seven
were statistically significant through the Mann–Whitney test
and  four  spots  through  the  Student’s  t-test  distribution.
Among the eight spots upregulated in the Aspergillus tear
samples,  upregulation  of  six  spots  were  statistically
significant through Mann–Whitney test and two spots through
the Student’s t-test distribution.
DISCUSSION
Our findings show that tears can be used as a clinical source
to  study  the  proteomic  responses  in  patients  with  fungal
keratitis. The presence of glutaredoxin-related protein in the
tears of patients with fungal keratitis implies that the fungus
undergoes  stress-related  gene  expression  during  infection
[33]. The 2DE gel map showed significant differences in the
protein  expression  between  the  control  and  infected  tear
samples.  Further  analysis  will  give  insight  into  the
pathogenesis of the disease.
Tear  protein  profile  by  2DE  analysis:  Like  most
techniques, the quality of the 2DE analysis depends on the
preparation of the sample. Since the volume of the tear sample
is usually limited to few microliters, the samples were pooled
in some experiments and were precipitated to remove salts.
Sufficient resolving power and reproducibility are also needed
for  comparative  proteome  analysis.  Our  electrophoretic
procedure and staining method, which is described under the
Methods  section,  were  optimized  for  the  analysis  of  tear
proteome  using  2DE.  The  removal  of  highly  abundant
proteins is essential to further improve the resolution. Even
with the current gels, we could clearly show the variation in
expression of selected spots with statistical confidence. Each
sample  was  examined  at  least  four  times  to  ensure  the
variability of the observed changes.
Significance  of  glutaredoxin-related  protein:  The
glutaredoxin-related protein was found to be expressed only
in the infected tear samples and absent in the control tear
samples.  Glutaredoxins  (GRXs)  are  oxidoreductases  that
protect cells against oxidative stress [34,35] and are required
for the activity of specific enzymes [36]. GRX has been found
in bacteria, yeasts, and higher eukaryotes [36,37]. These are
ubiquitous small heat-stable oxidoreductases that are involved
in many cellular processes, including deoxyribonucleotide
synthesis, the repair of oxidatively damaged proteins, protein
folding, and sulfur metabolism [35]. GRXs contain cysteine
residues  in  the  conserved  region  [38,39]  and  can  be
subdivided  into  two  subfamilies,  dithiol  GRXs  with  the
carboxypeptidase Y/ferrichrome (CPY/FC) active site motif
and monothiol GRXs with the CGFS motif. Both subfamilies
share a thioredoxin-fold structure. Some monothiol GRXs
exist  with  a  single-Grx  domain  while  others  have  a
thioredoxin-like domain (Trx) and one or more Grx domain
in tandem. Most fungi have both dithiol and monothiol GRXs
with different subcellular locations. GRX-like molecules also
exist  in  fungi  that  differ  by  one  residue  from  one  of  the
canonical active site motifs.
Glutaredoxin  is  also  known  to  be  expressed  by
Aspergillus under oxidative stress conditions [33]. The major
antioxidant  molecules  and  interconnecting  pathways  are
active in Aspergillus, and it has the entire armamentarium to
combat oxidative stress [33,40]. Thus, the presence of this
glutaredoxin-related protein only in the fungal-infected tear
Figure 1. Representative 2DE gel map of tear proteins of normal subjects and fungal keratitis patients. Tear proteins (270 μg) were separated
using an 18 cm pH 3–10 NL IPG strip in the first dimension and 12.5% SDS–PAGE followed by coomassie blue G-250 staining in the second
dimension. The identified normal tear proteins, cystatin S precursor (spot 1), cystatin SN precursor (spot 5), cystatin (spot 29), human tear
lipocalin (spot 49), prolactin inducible protein (spot 34), serum albumin (spot 44), and fungal protein such as the glutaredoxin-related protein
(spot 54) are marked and compared between control tear samples, Fusarium keratitis tear samples, and Aspergillus keratitis tear samples.
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which were differentially expressed in
the tears of mycotic keratitis patients.
Among  six  normal  tear  proteins
identified,  four  proteins  (cystatin  S
precursor [1], cystatin SN precursor [5],
cystatin [29], and human tear lipocalin
[49])  were  downregulated  and  two
proteins  (prolactin  inducible  protein
[34] and serum albumin precursor [44])
were upregulated in fungal keratitis” in
“Among  six  normal  tear  proteins
identified,  four  proteins  (cystatin  S
precursor,  cystatin  SN  precursor,
cystatin, and human tear lipocalin) were
downregulated  and  two  proteins
(prolactin inducible protein and serum
albumin precursor) were upregulated in
fungal keratitis.
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search against the Homo sapiens database did not give any hit
for the MALDI data whereas the fungal database gave an
excellent Mascot score. Interestingly, the protein expression
was higher in the Aspergillus-infected tear sample than in the
Fusarium-infected tear sample. Further studies are needed
with a large number of samples to give insight about the
contribution of this protein to the pathophysiological process
of  mycotic  keratitis.  Further  analysis  using  tear  samples
collected from various stages of fungal keratitis is in progress
to understand the validation of using this protein as a marker
associated  with  the  severity,  progression,  or  therapeutic
response of keratitis.
Functional  implication  of  differentially  expressed
proteins: The up and downregulation of proteins can provide
important information about disease processes and can lead
to a better understanding of the pathogenesis. Furthermore,
this  process  might  identify  important  biomarkers  of  the
disease and thus will lead to predictive medicine.
Table 1 describes the functional activity of identified
proteins.  Since  the  levels  of  some  identified  normal  tear
proteins decreased in the patient group, the downregulation of
these proteins may affect the function of tear film. The first
line of protection of the eye depends on the nature of the
protein components present in the secretion. Besides secretory
IgA, four proteins (lysozyme, lactoferrin, cystatin, and tear
lipocalin) make up nearly 50% of the protein.
The  role  of  cystatins  as  proteinase  inhibitors  is  well
established.  The  balance  between  protease  and  protease
inhibitor is believed to play a significant role in maintaining
the  normal  ocular  surface  condition  [41].Cystatins  are
generally tight-binding inhibitors of cysteine proteases and
have  a  protective  function  by  regulating  the  activities  of
endogenous  cysteine  proteases  causing  uncontrolled
proteolysis  and  tissue  damages  [42-45].  The  reduction  of
cystatins in the tears of patients with fungal keratitis correlates
well  with  their  functional  role  since  cysteine  protease
inhibitors  were  demonstrated  to  be  reduced  in  several
pathological conditions [46].
The tear lipocalin protein level in human tears ranges
between 0.5 and 1.5 g/l, making up 10%–20% of the total tear
protein  content  in  tears  and  is  considered  tear-specific
[47-49].The origin and concentration of lipocalin in tears may
reflect an important function of this protein on the ocular
surface [50]. The possible role for lipocalin is the transport of
lipids [51]. It is previously called tear-specific prealbumin
[52]. It has been shown that lipocalin is synthesized in the
main and accessory lacrimal glands. Studies on tear samples
from normal subjects and keratoconjunctivitis sicca patients
showed that lipocalin may serve as the marker protein for
lacrimal gland functions.
Prolactin inducible protein (PIP) has been found in tears,
saliva, sweat, seminal plasma, submucosal gland of the lung,
and amniotic fluid and was shown to be involved in local
immune function. It is also capable of suppressing T-cell
apoptosis  in  the  reproductive  system  via  high-affinity
interaction with CD4 [23].
Overall, in this study, the 2DE profile of fungal keratitis
patients were compared to those of healthy volunteers and
downregulated proteins were found which are associated with
the disease. The presence of the glutaredoxin-related protein
exclusively  in  the  tears  of  patients  with  fungal  keratitis
indicates that the fungus might undergo stress-related gene
expression during infection. The tear proteomic analysis could
be applied to understand the disease mechanism and to find
new diagnostic or therapeutic targets as well as classification
of disease state.
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TABLE 1. FUNCTIONAL ACTIVITY OF IDENTIFIED PROTEINS AND ITS REGULATION IN THE FUNGAL KERATITIS PATIENT.




Regulation in infected tear Function
Cystatin S precursor 1 122 (>64) Downregulation Cysteine protease inhibitor
Cystatin SN precursor 5 66 (>55) Downregulation Cysteine protease inhibitor
Cystatin 29 67 (>60) Downregulation Cysteine protease inhibitor
Human tear lipocalin 49 72 (>64) Downregulation Lipid scavenging and transport to
outer tear layer
Prolactin inducible protein 34 92 (>64) Upregulation Suppressing T-cell apoptosis
Serum albumin precursor 44 112 (>67) Upregulation Regulation of the colloidal osmotic
pressure of blood
Glutaredoxin-related protein 54 58 (>65) Upregulation Protect cells against oxidative stress
Six normal tear proteins were identified in healthy subjects and fungal keratitis patients with varied regulation. Glutaredoxin
related protein was expressed only in fungal keratitis patients. The identified proteins are listed in the order of their regulations.
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